TKNO

Alpha Teknova, Inc. (TKNO) | Rumor.io

Alpha Teknova

TKNO

Attention (50-day avg)0%

Attention rank (50-day avg)#3,635

Bullish sentiment (50-day avg)100%

Price to earnings ratio-28.7

Market capitalization493.9M

Earnings per share-0.31

Dividend yield (TTM)—

Revenue (annual)40.5M

Net income (annual)-17.3M

Social

What share of all stock conversation is about TKNO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% new	0% +0	0% 0

Mar 10

The CFO of Alpha Teknova, Inc. (TKNO) has increased their position by 31% to 168,376 shares, with a recent purchase of 40,000 shares at $2.19.
Director Stephen Gunstream has also bought 26,000 shares of TKNO at $2.12, with the stock's 52-week high being $7.48 and its current price near the 52-week low of $1.91.
The recent insider buying activity in TKNO has been viewed as a positive signal, with the stock experiencing a decline of 63% from its 52-week high.

Generated by AI

Sentiment

Of the messages about TKNO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	95% +8.33
Bearish	—	—	—	5% -8.33

Jul 17

Insider buying activity at Alpha Teknova, Inc. ($TKNO) is a strong bullish signal, with the CEO and other executives purchasing millions of shares at current low prices.
The company's CEO has recently bought $100K in common stock, and insiders have collectively purchased over 12 million shares, indicating a high level of confidence in the stock's potential.
Technical analysis suggests that $TKNO is poised to break through key resistance levels, potentially reaching prices as high as $3.53 if it can hold above $2.71.

Generated by AI

Topics

Of the messages about TKNO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	63.41%
Analysts	—	—	0%	2.44%
Controversies	—	—	0%	2.44%
Earnings	—	—	0%	4.88%
Macro	—	—	0%	0%
Technical Analysis	—	—	0%	26.83%

Community

Of the messages about TKNO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	0%	0%	2.13%
Newcomers	—	100%	100%	97.87%

Mar 10

Newcomers are noticing insider buying in TKNO, with CFO Lowell Matthew and Director Gunstream Stephen making purchases, indicating a potential increase in share value.
The stock price of TKNO has dropped by 63% from its 52-week high, and newcomers are speculating about the underlying reasons for this decline.
The insider buying by CFO Lowell Matthew and Director Gunstream Stephen has sparked a 6/10 signal, indicating a moderate level of interest and potential for future price movement.

Generated by AI

Alpha Teknova (TKNO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

7d agoYahoo Finance

Analysts Conflicted on These Healthcare Names: Envista Holdings (NVST), Alpha Teknova (TKNO) and Adaptive Biotechnologies (ADPT)

Detailed price information for Envista Holdings Corp (NVST-N) from The Globe and Mail including charting and trades.

11d agoThe Globe and Mail

Alpha Teknova Raises Outlook After Record Q2 Revenue at Sidoti Conference

Alpha Teknova (NASDAQ:TKNO) Chief Financial Officer Matt Lowell said the provider of laboratory and bioprocessing reagents is seeing renewed growth, reporting record second-quarter revenue and raising its full-year outlook as biopharma funding and life-science end markets improve. Speaking at the S

1mo agoYahoo Finance

Also Discussed

Investors talking about TKNO also mention

#	Name	Attention
1	Baird Medical Investment Holdings Ltd.BDMD	0%new
2	Zentalis Pharmaceuticals, Inc.ZNTL	0%new
3	MKDWELL Tech Inc.MKDW	0%+0
4	NN, Inc.NNBR	0%0
5	AmpliTech Group, Inc.AMPG	0%0
6	Verrica Pharmaceuticals Inc.VRCA	0%0
7	OneConstruction Group Ltd.ONEG	0%0
8	TTEC Holdings, Inc.TTEC	0%0
9	P3 Health Partners Inc. Class A Common StockPIII	0%new
10	Agape Atp CorpATPC	0%0

Alpha Teknova, Inc.

Healthcare
Drug Manufacturers - Specialty & Generic

Alpha Teknova, Inc. is a life sciences reagents company that develops and manufactures products used in research, bioprocessing, and molecular diagnostics. Its offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements, and molecular biology reagents for sample manipulation, resuspension, and purification. The company serves a broad customer base across the biotechnology, pharmaceutical, diagnostics, academic, and government research markets, supporting workflows tied to drug development, vaccine development, and advanced therapies. Alpha Teknova also provides custom and catalog solutions designed for laboratory and manufacturing applications, with products used in cell and gene therapy, synthetic biology, and other life science workflows. Headquartered in Hollister, California, Alpha Teknova plays a specialized role in the supply chain that enables scientific research and the production of biopharmaceutical products.

Website

Location

2451 Bert Dr.

Hollister, CA, 95023

United States

Social

What share of all stock conversation is about TKNO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% new	0% +0	0% 0

Mar 10

The CFO of Alpha Teknova, Inc. (TKNO) has increased their position by 31% to 168,376 shares, with a recent purchase of 40,000 shares at $2.19.
Director Stephen Gunstream has also bought 26,000 shares of TKNO at $2.12, with the stock's 52-week high being $7.48 and its current price near the 52-week low of $1.91.
The recent insider buying activity in TKNO has been viewed as a positive signal, with the stock experiencing a decline of 63% from its 52-week high.

Generated by AI

Sentiment

Of the messages about TKNO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	95% +8.33
Bearish	—	—	—	5% -8.33

Jul 17

Insider buying activity at Alpha Teknova, Inc. ($TKNO) is a strong bullish signal, with the CEO and other executives purchasing millions of shares at current low prices.
The company's CEO has recently bought $100K in common stock, and insiders have collectively purchased over 12 million shares, indicating a high level of confidence in the stock's potential.
Technical analysis suggests that $TKNO is poised to break through key resistance levels, potentially reaching prices as high as $3.53 if it can hold above $2.71.

Generated by AI

Topics

Of the messages about TKNO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	63.41%
Analysts	—	—	0%	2.44%
Controversies	—	—	0%	2.44%
Earnings	—	—	0%	4.88%
Macro	—	—	0%	0%
Technical Analysis	—	—	0%	26.83%

Community

Of the messages about TKNO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	0%	0%	2.13%
Newcomers	—	100%	100%	97.87%

Mar 10

Newcomers are noticing insider buying in TKNO, with CFO Lowell Matthew and Director Gunstream Stephen making purchases, indicating a potential increase in share value.
The stock price of TKNO has dropped by 63% from its 52-week high, and newcomers are speculating about the underlying reasons for this decline.
The insider buying by CFO Lowell Matthew and Director Gunstream Stephen has sparked a 6/10 signal, indicating a moderate level of interest and potential for future price movement.

Generated by AI

Alpha Teknova

Social

Mar 10

Sentiment

Jul 17

Topics

Community

Mar 10

News

Alpha Teknova (TKNO) Moves 7.1% Higher: Will This Strength Last?

Analysts Conflicted on These Healthcare Names: Envista Holdings (NVST), Alpha Teknova (TKNO) and Adaptive Biotechnologies (ADPT)

Jefferies initiates Alpha Teknova stock with buy on growth outlook

Teknova launches Fill-Tek dispensing system for custom reagents

Alpha Teknova: Ample Manufacturing Capacity At A High Premium (NASDAQ:TKNO)

Alpha Teknova Raises Outlook After Record Q2 Revenue at Sidoti Conference

Also Discussed

Alpha Teknova, Inc.

Company Information

Location

News

Alpha Teknova (TKNO) Moves 7.1% Higher: Will This Strength Last?

Analysts Conflicted on These Healthcare Names: Envista Holdings (NVST), Alpha Teknova (TKNO) and Adaptive Biotechnologies (ADPT)

Jefferies initiates Alpha Teknova stock with buy on growth outlook

Teknova launches Fill-Tek dispensing system for custom reagents

Alpha Teknova: Ample Manufacturing Capacity At A High Premium (NASDAQ:TKNO)

Alpha Teknova Raises Outlook After Record Q2 Revenue at Sidoti Conference

Also Discussed

Social

Mar 10

Sentiment

Jul 17

Topics

Community

Mar 10